Co-Authors
This is a "connection" page, showing publications co-authored by Peter Cherepanov and Laura McCoy.
Connection Strength
1.161
-
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity. Sci Adv. 2021 05; 7(22).
Score: 0.237
-
The effect of spike mutations on SARS-CoV-2 neutralization. Cell Rep. 2021 03 23; 34(12):108890.
Score: 0.233
-
SARS-CoV-2 antibody responses in patients with acute leukaemia. Leukemia. 2021 01; 35(1):289-292.
Score: 0.229
-
Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort. Crit Care Explor. 2021 Aug; 3(8):e0488.
Score: 0.060
-
Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort. Br J Anaesth. 2021 08; 127(2):e75-e78.
Score: 0.059
-
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection. Kidney Int Rep. 2021 Jul; 6(7):1799-1809.
Score: 0.059
-
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. Immunity. 2021 06 08; 54(6):1276-1289.e6.
Score: 0.059
-
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020 12 11; 370(6522):1339-1343.
Score: 0.057
-
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020 08; 38(8):1000.
Score: 0.056
-
Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020 08; 38(8):927-931.
Score: 0.056
-
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet. 2020 07 25; 396(10246):e6-e7.
Score: 0.056